Please login to the form below
MSD appoints new UK head
Mike Nally moves from Swedish division
Merck Sharp and Dohme (MSD) has announced that Mike Nally is to take on the role of managing director of the company's operations in the UK and Ireland.
Nally will take over the role on January 1, 2014, moving from his current position as managing director of MSD in Sweden.
He replaces Deepak Khanna who has been appointed to a new senior VP role at MSD where he will lead the company's oncology efforts across Europe.
As previously announced, Khanna will also step down from his role as president of the Association of the British Pharmaceutical Industry (ABPI) to be replaced by Pfizer's Jonathan Emms.
Commenting on Nally's work in Sweden, MSD said that “he has led the company to become a more customer centric organisation in a dynamic, payer-based environment”.
Featured jobs
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Client Services Director - Digital MedComms
-
£60000 - £80000 per annum, Benefits: Pension, healthcare, dedicated training budget, regul
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Manager
-
£Competitive Salary
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Manager (PR)
-
Great Benefits
-
Experienced medical editor
-
Competitive salary and bonus scheme
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Healthcare Communications
-
Salary TBC
-
Senior External Communications Lead
-
£Competitive Salary
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Publications director
-
Competitive salary and bonus scheme
-
Account director
-
Competitive salary and bonus scheme
-
Account Director
-
£Competitive Salary
Subscribe to our email news alerts
- Genital herpes vaccine candidate heads for human studies
- AZ revenues rise, but it says coronavirus could hit 2020
- Merck chases Roche with triple-negative breast cancer data for Keytruda
- China’s BrightGene successfully copies Gilead’s coronavirus hopeful remdesivir
- Novartis plans inclisiran trial in the UK
- Four more coronavirus cases confirmed in the UK
- Ex-Sandoz exec admits role in generic drug price-fixing plot
- Spotlight interview: 15 minutes on Independent Medical Education
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Merck’s Ebola vaccine wins approval in four African countries
- ReNeuron set for recovery after Woodford stake sale
- Servier and Oncodesign reach first milestone in Parkinson’s partnership
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...
Latest intelligence
- Enabling market access through outcomes-based pricing
- Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
- 20 for 2020 – Five pharma companies to watch
- As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
- The growing clinical importance of patient-reported outcomes (PROs)
- Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Quick links
Infographics
